Biosensors Market Poised for Significant Expansion as Chronic Diseases Increase

The biosensors market is valued at USD 25.5 billion in 2021 and is projected to reach USD 36.7 billion by 2026; it is expected to grow at a CAGR of 7.5% from 2021 to 2026.

In the fields of medicine, food safety, and environmental monitoring, biosensors are now indispensable tools. They are a category of analytical tool that changes a biological reaction into an electrical or optical signal. Glucose, enzymes, antibodies, and nucleic acids are just a few of the many biomolecules that can be detected and measured by biosensors. In the upcoming years, the market for biosensors is anticipated to expand quickly due to technical improvements and rising need for point-of-care testing.

The increasing prevalence of chronic diseases including diabetes, cancer, and cardiovascular diseases is one of the major factors driving the global market for biosensors. These disorders are diagnosed and monitored using biosensors, enabling early detection and individualised care. The market is also being driven by the growing use of biosensors in drug research and development. Drug targets are identified and measured using biosensors, which can result in the creation of safer and more effective medications.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=798

The expanding demand for point-of-care testing is another factor influencing the biosensors market. Point-of-care testing, as opposed to being completed in a centralised laboratory, describes medical diagnostic testing that is completed close to the patient. Point-of-care testing is a good fit for biosensors since they are portable, simple to use, and yield quick results. By enabling quicker and more precise diagnoses, the use of biosensors in point-of-care testing can assist to improve patient outcomes.

Despite the many benefits of biosensors, there are several issues that must be resolved in order to propel the market's expansion. The expensive price of biosensors, which can restrict their adoption in specific situations, is one of the key obstacles. Also, the quality and accuracy of biosensors may vary due to a lack of regulation and standardisation in the market.

Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Cytiva (UK), Dexcom, Inc. (US), Lifescan IP Holdings, LLC (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), ACON Laboratories, Inc. (US), CARDEA BIO INC., (US), Conductive Technologies (US), EarlySense (Israel), Innovative Sensor Technology IST AG (Switzerland), LifeSignals (US), NeuroSky (US), Pinnacle Technology Inc. (US), SD Biosensor, INC. (South Korea), VitalConnect (US), and Xsensio (Switzerland) are a few of the key players in the biosensors market.

Know more @ https://www.marketsandmarkets.com/Market-Reports/biosensors-market-798.html

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ’GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441